Prominent Cancer Researcher Resigns through Dartmouth Amid Plagiarism Charges

One of the country’s most influential researchers in cancer screening has resigned through his post at Dartmouth College, after a two-year internal investigation concluded he had plagiarized a graph included in a paper published in a prominent journal.

The researcher, Dr. H. Gilbert Welch, has published widely on the risks of aggressive screening in addition to also over-diagnosis, including Op-Ed articles inside the Times in addition to also several well-known books. He disputed the university’s findings against him.

“I am saddened to say of which I am resigning through Dartmouth,” Dr. Welch wrote in an email to colleagues. “I feel of which I can no longer participate inside the research misconduct process against me — as I fear my participation only serves to validate of which.”

In a prepared statement, Dartmouth said the university had “reviewed This particular matter in accordance with its research misconduct policy in addition to also procedures, which defines plagiarism as ‘the appropriation of another person’s ideas, processes, results or words without giving them appropriate credit,’” in addition to also found Dr. Welch guilty.

In his letter to colleagues, Dr. Welch said Dartmouth demanded of which he ask the brand new England Journal make Dr. Soneji the first author of the paper, in addition to also forfeit his teaching privileges, to remain at the medical school.

He refused.

“I cannot in Great conscience accept the demand of which I make the complainant an author — much less the demand of which I make him the first author,” he wrote. “Doing so requires of which I falsely attest of which he meets the requirements of authorship: namely, of which he materially participated inside the work in addition to also can be able to defend of which. Much as I have enjoyed working at Dartmouth, I am not willing to falsely attest to anything simply to stay here.”

Dr. Welch’s research in addition to also commentary had prompted health officials worldwide to review their cancer screening guidelines, which he found often led to over-diagnosis in addition to also unnecessary treatments.